Logistics and freight forwarding company Expeditors (NYSE:EXPD) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.8% year on year to $2.67 billion. Its GAAP profit of $1.47 per share was 9.1% above analysts’ consensus estimates.
Casual restaurant chain Portillo’s (NASDAQ:PTLO) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 6.4% year on year to $176.4 million. Its GAAP profit of $0.05 per share was in line with analysts’ consensus estimates.
Dredging and coastal protection company Great Lakes Dredge & Dock (NASDAQ:GLDD) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 22.3% year on year to $242.9 million. Its GAAP profit of $0.49 per share was 86.7% above analysts’ consensus estimates.
Railway infrastructure company L.B. Foster (NASDAQ:FSTR) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 21.3% year on year to $97.79 million. On the other hand, the company’s full-year revenue guidance of $560 million at the midpoint came in 3% above analysts’ estimates. Its GAAP loss of $0.20 per share was significantly below analysts’ consensus estimates.
Solar tracking systems manufacturer Array (NASDAQ:ARRY) announced better-than-expected revenue in Q1 CY2025, with sales up 97.1% year on year to $302.4 million. The company’s full-year revenue guidance of $1.1 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $0.13 per share was 47.4% above analysts’ consensus estimates.
Snack food company J&J Snack Foods (NASDAQ:JJSF) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 1% year on year to $356.1 million. Its non-GAAP profit of $0.35 per share was 48.5% below analysts’ consensus estimates.
B2B travel services company Global Business Travel (NYSE:GBTG) fell short of the market’s revenue expectations in Q1 CY2025 as sales only rose 1.8% year on year to $621 million. Next quarter’s revenue guidance of $625 million underwhelmed, coming in 4.2% below analysts’ estimates. Its GAAP profit of $0.16 per share was 78.5% above analysts’ consensus estimates.
Cruise and exploration company Lindblad Expeditions (NASDAQ:LIND) announced better-than-expected revenue in Q1 CY2025, with sales up 17% year on year to $179.7 million. The company’s full-year revenue guidance of $725 million at the midpoint came in 2.1% above analysts’ estimates. Its GAAP loss of $0 per share was significantly above analysts’ consensus estimates.
China's mainland markets re-opened after the extended holiday, and by setting the dollar's reference rate little changed from its last fix, helped inject a note of stability into the local Asian currencies.
Automotive services company Driven Brands (NASDAQ:DRVN) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 9.8% year on year to $516.2 million. The company expects the full year’s revenue to be around $2.1 billion, close to analysts’ estimates. Its non-GAAP profit of $0.27 per share was 12.9% above analysts’ consensus estimates.
Solar energy systems company Shoals (NASDAQ:SHLS) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 11.2% year on year to $80.63 million. On top of that, next quarter’s revenue guidance ($105 million at the midpoint) was surprisingly good and 10.4% above what analysts were expecting. Its non-GAAP profit of $0.03 per share was in line with analysts’ consensus estimates.
DoorDash (DASH) stock declined after reporting its Q1 results, beating earnings but missing revenue estimates. Plans to acquire Deliveroo and SevenRooms.
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $233.4 million. On the other hand, next quarter’s revenue guidance of $235 million was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.74 per share was 9.9% above analysts’ consensus estimates.
Electric vehicle charging company EVgo (NASDAQ:EVGO) announced better-than-expected revenue in Q1 CY2025, with sales up 36.5% year on year to $75.29 million. The company’s full-year revenue guidance of $360 million at the midpoint came in 2.3% above analysts’ estimates. Its GAAP loss of $0.09 per share was in line with analysts’ consensus estimates.
Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $2.70 per share was 2.6% above analysts’ consensus estimates.
